Regencell Bioscience (RGC) vs USANA Health Sciences (USNA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
USANA Health Sciences (USNA) has outperformed Regencell Bioscience (RGC) over the past year, losing 44.7% versus a loss of 60.7%. Over five years, RGC leads with a +1455.6% price change compared with -85.2% for USNA.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | RGC | USNA |
|---|---|---|
| Share price | $7.63 | $14.66 |
| Market cap | — | $270.87M |
| 1-day change | +7.31% | -0.07% |
| YTD return | -63.67% | -25.32% |
| 1-year return | -60.67% | -44.70% |
| 5-year return | +1455.56% | -85.20% |
| Forward P/E | — | 8.28 |
| EPS (TTM) | $-0.02 | $-1.20 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | $-11.70M | — |
| 52-week high | $69.00 | $24.33 |
| 52-week low | $4.51 | $12.57 |
| Distance from 52-week high | -88.94% | -39.75% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +70.53% |
| Average volume | 199.19K | 186.75K |
| Shares outstanding | — | 18.48M |
| Employees | 10 | 1,570 |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- USNA has outperformed RGC by 16.0 percentage points over the past year.
About Regencell Bioscience
RGC stock →Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder.
Health Care · Medicinal Chemicals and Botanical Products · 10 employees
About USANA Health Sciences
USNA stock →USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe.
Health Care · Medicinal Chemicals and Botanical Products · 1,570 employees
RGC vs USNA FAQ
Which stock has performed better over the past year, RGC or USNA?
USNA returned -44.70% over the past 12 months, compared with -60.67% for RGC (price return, excluding dividends). Past performance does not predict future results.
Are Regencell Bioscience and USANA Health Sciences in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.